DG Health Nasal Spray Recalled for Contaminated Excipient
Perrigo Company PLC is recalling DG Health Nasal Spray (Oxymetazoline HCl 0.05%) distributed nationwide because the product was manufactured with a contaminated excipient that was itself recalled from the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a cGMP deviation—use of a contaminated excipient. The source text does not report any illnesses, injuries, or deaths, and the hazard is a manufacturing compliance issue rather than a known pathogen or established safety threat. This fits the Moderate category for a Class II precautionary recall.
Plain-English summary
Perrigo Company PLC is recalling DG Health Nasal Severe Congestion No Drip Nasal Spray Plus Menthol (Oxymetazoline HCl 0.05%, 1 FL Oz / 30 mL bottles, NDC 55910-511-10) distributed nationwide in the United States. The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled by the excipient supplier.
Affected batches include: 1BK0716 (Exp 12/31/2022), 1CK0899 (Exp 01/31/2023), and 1FK1163 (Exp 01/31/2023).
The recalled product was distributed by Dolgencorp, LLC, located at 100 Mission Ridge, Goodlettsville, TN 37072. Consumers who have purchased this product should stop using it and consult with a healthcare provider if they have questions or concerns about their use of the recalled product.
The recalled product
- Product
- DG HEALTH NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- DG HEALTH NASAL
- Manufacturer
- Perrigo Company PLC
- Affected units
- 214,824
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batch: 1BK0716
- Exp 12/31/2022)
- 1CK0899
- Exp 01/31/2023
- 1FK1163
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same brand · DG HEALTH NASAL
- ModerateDG Health Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09